Global Veterinary Pharmaceuticals Market: By Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Veterinary Pharmaceuticals Market Report Description:
Veterinary pharmaceuticals market report gives comprehensive outlook on Veterinary pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary pharmaceuticals market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies veterinary pharmaceuticals market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, veterinary pharmaceuticals market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary pharmaceuticals market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary pharmaceuticals market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary pharmaceuticals.
Global Veterinary Pharmaceuticals Market:
Global veterinary pharmaceuticals market estimated to be valued US$ 18.1 Bn in 2017 and poised to grow at CAGR of 6.2% over 2017-2023. Market for veterinary pharmaceuticals projected to reach US$ 25.9 Bn by 2023 owing to rise in meat consumption and increased incidence of zoonotic diseases.
The rising demand for protein food expected to dive veterinary pharmaceutical market revenue growth
The demand for protein food such as meat, milk, and eggs across the different geographies expected to drive market for veterinary pharmaceuticals across the globe. Moreover, the rising demand for meat prompt the cattlemen and slaughter houses to adopt good hygienic practices to provide better healthcare to the cattle and livestock animals, which projected to boost market revenue growth of veterinary pharmaceuticals over the forecast period. As per UN Food and Agricultural Organization (FAO) estimates that animal protein production such as poultry, beef, swine are expected to double, as well as dairy, and fish production anticipated to grow triple by 2050.
Limited Research and development activities dampening the market revenue growth
Veterinary pharmaceutical market growth expected to hinder owing to dearth of research and development activities and limited new drug approvals in the recent times. Players in the market focusing majorly on building existing portfolio that may lead to product maturity in near term and that may hamper the market growth over the forecast period. Moreover, competition from generic players and OTC drugs are hindering the market revenue growth
North America market leads the global veterinary pharmaceuticals market
Currently, North America market leads the global veterinary pharmaceuticals market and projected to remain same over the forecast period owing to rising consumption of protein food. Europe veterinary pharmaceuticals market holds significant share in global veterinary pharmaceuticals market and projected to grow at significant CAGR.
COMPETITION ASSESSMENT
Key players profiles in the global Veterinary Pharmaceuticals market include:
KEY FINDINGS OF THE REPORT:
By Product Type
Veterinary pharmaceuticals market report gives comprehensive outlook on Veterinary pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary pharmaceuticals market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies veterinary pharmaceuticals market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, veterinary pharmaceuticals market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary pharmaceuticals market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary pharmaceuticals market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary pharmaceuticals.
Global Veterinary Pharmaceuticals Market:
Global veterinary pharmaceuticals market estimated to be valued US$ 18.1 Bn in 2017 and poised to grow at CAGR of 6.2% over 2017-2023. Market for veterinary pharmaceuticals projected to reach US$ 25.9 Bn by 2023 owing to rise in meat consumption and increased incidence of zoonotic diseases.
The rising demand for protein food expected to dive veterinary pharmaceutical market revenue growth
The demand for protein food such as meat, milk, and eggs across the different geographies expected to drive market for veterinary pharmaceuticals across the globe. Moreover, the rising demand for meat prompt the cattlemen and slaughter houses to adopt good hygienic practices to provide better healthcare to the cattle and livestock animals, which projected to boost market revenue growth of veterinary pharmaceuticals over the forecast period. As per UN Food and Agricultural Organization (FAO) estimates that animal protein production such as poultry, beef, swine are expected to double, as well as dairy, and fish production anticipated to grow triple by 2050.
Limited Research and development activities dampening the market revenue growth
Veterinary pharmaceutical market growth expected to hinder owing to dearth of research and development activities and limited new drug approvals in the recent times. Players in the market focusing majorly on building existing portfolio that may lead to product maturity in near term and that may hamper the market growth over the forecast period. Moreover, competition from generic players and OTC drugs are hindering the market revenue growth
North America market leads the global veterinary pharmaceuticals market
Currently, North America market leads the global veterinary pharmaceuticals market and projected to remain same over the forecast period owing to rising consumption of protein food. Europe veterinary pharmaceuticals market holds significant share in global veterinary pharmaceuticals market and projected to grow at significant CAGR.
COMPETITION ASSESSMENT
Key players profiles in the global Veterinary Pharmaceuticals market include:
- Bayer AG (Germany)
- Boehringer Ingelheim GmbH (Germany)
- Ceva Santé Animale (France)
- Eli Lilly and Company (U.S)
- Heska Co. (U.S)
- Hester biosciences (India)
- Merck & Co., Inc. (U.S)
- Perrigo Company plc. (Ireland)
- Vétoquinol S.A. (France)
- Virbac S.A. (France)
- Zoetis Inc. (U.S)
KEY FINDINGS OF THE REPORT:
- Veterinary pharmaceuticals market expanding at 6.2% CAGR over 2017 to 2023 to reach market value of US$ 25.9 Bn by 2023
- Based on product type antimicrobials accounted for larger market revenue share in 2016 and projected gain larger market revenue share over the forecast period
- Veterinary pharmacies distribution channel is the prime source for veterinary pharmaceuticals across the globe and expected to remain attractive over the forecast period
- Players focusing on launching products to retain market position in global veterinary pharmaceuticals market
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Product Type
- Antimicrobials
- Ectoparasiticides
- Endoparacitides
- Endectoparaciticides
- Anti-inflammatory Drugs
- Anti-Obesity Drugs
- Behavioral Products
- Biologic Drugs
- Others
- Farm Animals
- Livestock
- Poultry
- Swine
- Equine
- Companion Animals
- Feline
- Canine
- Avian
- Aquaculture
- Oral
- Parenteral
- Topical
- Others
- Veterinary Pharmacies
- Veterinary Hospitals
- Veterinary Clinics
- E-Commerce
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL VETERINARY PHARMACEUTICALS MARKET DYNAMIC FACTORS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.1.1. Dash board of top players
5.1.2. Financial Analysis
5.1.3. Product & Services
5.1.4. Key Developments
5.1.5. Major Strategies
5.1.6. SWOT Analysis
5.2. Technological advancements in veterinary pharmaceuticals market
5.3. Recent investments in the industry
5.4. Regulatory landscape
5.4.1. U.S.
5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis
6. GLOBAL VETERINARY PHARMACEUTICALS MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Product Type
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.3. Antimicrobials
6.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.4. Ectoparasiticides
6.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.5. Endoparacitides
6.1.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.6. Endectoparaciticides
6.1.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.7. Anti-inflammatory Drugs
6.1.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.8. Anti-Obesity Drugs
6.1.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.9. Behavioral Products
6.1.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.10. Biologic Drugs
6.1.10.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.11. Others
6.1.11.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Farm Animals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.3. Livestock
7.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.4. Poultry
7.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.5. Swine
7.1.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.6. Equine
7.1.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Companion Animal
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.3. Feline
7.2.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.4. Canine
7.2.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.5. Avian
7.2.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Aqua Culture
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Oral
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Parenteral
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Topical
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Others
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Veterinary Hospitals
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. VETERINARY PHARMACEUTICALS MARKET FORECAST, BY REGION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.1.1. Product type
10.1.1.1.1. Antimicrobials
10.1.1.1.2. Ectoparasiticides
10.1.1.1.3. Endoparacitides
10.1.1.1.4. Endectoparaciticides
10.1.1.1.5. Anti-inflammatory Drugs
10.1.1.1.6. Anti-Obesity Drugs
10.1.1.1.7. Behavioral Products
10.1.1.1.8. Biologic Drugs
10.1.1.1.9. Others
10.1.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.2.1. Farm Animal
10.1.2.1.1. Livestock
10.1.2.1.2. Poultry
10.1.2.1.3. Swine
10.1.2.1.4. Equine
10.1.2.2. Companion Animal
10.1.2.2.1. Feline
10.1.2.2.2. Canine
10.1.2.2.3. Avian
10.1.2.2.4. Others
10.1.2.3. Aquaculture
10.1.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.3.1. Oral
10.1.3.2. Parenteral
10.1.3.3. Topical
10.1.3.4. Others
10.1.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.4.1. Veterinary Pharmacies
10.1.4.2. Veterinary Hospitals
10.1.4.3. Veterinary Clinics
10.1.4.4. E-Commerce
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.2. Europe Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.2.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.1.1. Product type
10.2.1.1.1. Antimicrobials
10.2.1.1.2. Ectoparasiticides
10.2.1.1.3. Endoparacitides
10.2.1.1.4. Endectoparaciticides
10.2.1.1.5. Anti-inflammatory Drugs
10.2.1.1.6. Anti-Obesity Drugs
10.2.1.1.7. Behavioral Products
10.2.1.1.8. Biologic Drugs
10.2.1.1.9. Others
10.2.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.2.1. Farm Animal
10.2.2.1.1. Livestock
10.2.2.1.2. Poultry
10.2.2.1.3. Swine
10.2.2.1.4. Equine
10.2.2.2. Companion Animal
10.2.2.2.1. Feline
10.2.2.2.2. Canine
10.2.2.2.3. Avian
10.2.2.2.4. Others
10.2.2.3. Aquaculture
10.2.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.3.1. Oral
10.2.3.2. Parenteral
10.2.3.3. Topical
10.2.3.4. Others
10.2.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.4.1. Veterinary Pharmacies
10.2.4.2. Veterinary Hospitals
10.2.4.3. Veterinary Clinics
10.2.4.4. E-Commerce
10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.5.1. Germany
10.2.5.2. UK
10.2.5.3. France
10.2.5.4. Spain
10.2.5.5. Italy
10.2.5.6. Russia
10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.3.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.1.1. Product type
10.3.1.1.1. Antimicrobials
10.3.1.1.2. Ectoparasiticides
10.3.1.1.3. Endoparacitides
10.3.1.1.4. Endectoparaciticides
10.3.1.1.5. Anti-inflammatory Drugs
10.3.1.1.6. Anti-Obesity Drugs
10.3.1.1.7. Behavioral Products
10.3.1.1.8. Biologic Drugs
10.3.1.1.9. Others
10.3.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.2.1. Farm Animal
10.3.2.1.1. Livestock
10.3.2.1.2. Poultry
10.3.2.1.3. Swine
10.3.2.1.4. Equine
10.3.2.2. Companion Animal
10.3.2.2.1. Feline
10.3.2.2.2. Canine
10.3.2.2.3. Avian
10.3.2.2.4. Others
10.3.2.3. Aquaculture
10.3.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.3.1. Oral
10.3.3.2. Parenteral
10.3.3.3. Topical
10.3.3.4. Others
10.3.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.4.1. Veterinary Pharmacies
10.3.4.2. Veterinary Hospitals
10.3.4.3. Veterinary Clinics
10.3.4.4. E-Commerce
10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.5.1. Japan
10.3.5.2. China
10.3.5.3. India
10.3.5.4. ASEAN
10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.4.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.1.1. Product type
10.4.1.1.1. Antimicrobials
10.4.1.1.2. Ectoparasiticides
10.4.1.1.3. Endoparacitides
10.4.1.1.4. Endectoparaciticides
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL VETERINARY PHARMACEUTICALS MARKET DYNAMIC FACTORS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.1.1. Dash board of top players
5.1.2. Financial Analysis
5.1.3. Product & Services
5.1.4. Key Developments
5.1.5. Major Strategies
5.1.6. SWOT Analysis
5.2. Technological advancements in veterinary pharmaceuticals market
5.3. Recent investments in the industry
5.4. Regulatory landscape
5.4.1. U.S.
5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis
6. GLOBAL VETERINARY PHARMACEUTICALS MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Product Type
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.3. Antimicrobials
6.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.4. Ectoparasiticides
6.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.5. Endoparacitides
6.1.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.6. Endectoparaciticides
6.1.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.7. Anti-inflammatory Drugs
6.1.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.8. Anti-Obesity Drugs
6.1.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.9. Behavioral Products
6.1.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.10. Biologic Drugs
6.1.10.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.11. Others
6.1.11.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Farm Animals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.3. Livestock
7.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.4. Poultry
7.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.5. Swine
7.1.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.6. Equine
7.1.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Companion Animal
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.3. Feline
7.2.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.4. Canine
7.2.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.5. Avian
7.2.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Aqua Culture
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Oral
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Parenteral
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Topical
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Others
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL VETERINARY PHARMACEUTICALS MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Veterinary Hospitals
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. VETERINARY PHARMACEUTICALS MARKET FORECAST, BY REGION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.1.1. Product type
10.1.1.1.1. Antimicrobials
10.1.1.1.2. Ectoparasiticides
10.1.1.1.3. Endoparacitides
10.1.1.1.4. Endectoparaciticides
10.1.1.1.5. Anti-inflammatory Drugs
10.1.1.1.6. Anti-Obesity Drugs
10.1.1.1.7. Behavioral Products
10.1.1.1.8. Biologic Drugs
10.1.1.1.9. Others
10.1.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.2.1. Farm Animal
10.1.2.1.1. Livestock
10.1.2.1.2. Poultry
10.1.2.1.3. Swine
10.1.2.1.4. Equine
10.1.2.2. Companion Animal
10.1.2.2.1. Feline
10.1.2.2.2. Canine
10.1.2.2.3. Avian
10.1.2.2.4. Others
10.1.2.3. Aquaculture
10.1.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.3.1. Oral
10.1.3.2. Parenteral
10.1.3.3. Topical
10.1.3.4. Others
10.1.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.4.1. Veterinary Pharmacies
10.1.4.2. Veterinary Hospitals
10.1.4.3. Veterinary Clinics
10.1.4.4. E-Commerce
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.2. Europe Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.2.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.1.1. Product type
10.2.1.1.1. Antimicrobials
10.2.1.1.2. Ectoparasiticides
10.2.1.1.3. Endoparacitides
10.2.1.1.4. Endectoparaciticides
10.2.1.1.5. Anti-inflammatory Drugs
10.2.1.1.6. Anti-Obesity Drugs
10.2.1.1.7. Behavioral Products
10.2.1.1.8. Biologic Drugs
10.2.1.1.9. Others
10.2.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.2.1. Farm Animal
10.2.2.1.1. Livestock
10.2.2.1.2. Poultry
10.2.2.1.3. Swine
10.2.2.1.4. Equine
10.2.2.2. Companion Animal
10.2.2.2.1. Feline
10.2.2.2.2. Canine
10.2.2.2.3. Avian
10.2.2.2.4. Others
10.2.2.3. Aquaculture
10.2.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.3.1. Oral
10.2.3.2. Parenteral
10.2.3.3. Topical
10.2.3.4. Others
10.2.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.4.1. Veterinary Pharmacies
10.2.4.2. Veterinary Hospitals
10.2.4.3. Veterinary Clinics
10.2.4.4. E-Commerce
10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.5.1. Germany
10.2.5.2. UK
10.2.5.3. France
10.2.5.4. Spain
10.2.5.5. Italy
10.2.5.6. Russia
10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.3.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.1.1. Product type
10.3.1.1.1. Antimicrobials
10.3.1.1.2. Ectoparasiticides
10.3.1.1.3. Endoparacitides
10.3.1.1.4. Endectoparaciticides
10.3.1.1.5. Anti-inflammatory Drugs
10.3.1.1.6. Anti-Obesity Drugs
10.3.1.1.7. Behavioral Products
10.3.1.1.8. Biologic Drugs
10.3.1.1.9. Others
10.3.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.2.1. Farm Animal
10.3.2.1.1. Livestock
10.3.2.1.2. Poultry
10.3.2.1.3. Swine
10.3.2.1.4. Equine
10.3.2.2. Companion Animal
10.3.2.2.1. Feline
10.3.2.2.2. Canine
10.3.2.2.3. Avian
10.3.2.2.4. Others
10.3.2.3. Aquaculture
10.3.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.3.1. Oral
10.3.3.2. Parenteral
10.3.3.3. Topical
10.3.3.4. Others
10.3.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.4.1. Veterinary Pharmacies
10.3.4.2. Veterinary Hospitals
10.3.4.3. Veterinary Clinics
10.3.4.4. E-Commerce
10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.5.1. Japan
10.3.5.2. China
10.3.5.3. India
10.3.5.4. ASEAN
10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Veterinary Pharmaceuticals Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.4.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.1.1. Product type
10.4.1.1.1. Antimicrobials
10.4.1.1.2. Ectoparasiticides
10.4.1.1.3. Endoparacitides
10.4.1.1.4. Endectoparaciticides
